Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

OSL:BNOR - Euronext Oslo - NO0010379266 - Common Stock - Currency: NOK

583.5  +3.5 (+0.6%)

Fundamental Rating

3

Taking everything into account, BNOR scores 3 out of 10 in our fundamental rating. BNOR was compared to 58 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of BNOR have multiple concerns. BNOR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BNOR has reported negative net income.
In the past year BNOR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BNOR reported negative net income in multiple years.
Each year in the past 5 years BNOR had a positive operating cash flow.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -2.05%, BNOR is not doing good in the industry: 84.48% of the companies in the same industry are doing better.
BNOR has a Return On Equity of -10.18%. This is amonst the worse of the industry: BNOR underperforms 89.66% of its industry peers.
BNOR has a Return On Invested Capital of 5.67%. This is in the lower half of the industry: BNOR underperforms 65.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BNOR is significantly below the industry average of 15.08%.
Industry RankSector Rank
ROA -2.05%
ROE -10.18%
ROIC 5.67%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

BNOR has a Operating Margin of 31.11%. This is in the better half of the industry: BNOR outperforms 68.97% of its industry peers.
In the last couple of years the Operating Margin of BNOR has grown nicely.
BNOR has a better Gross Margin (55.79%) than 62.07% of its industry peers.
In the last couple of years the Gross Margin of BNOR has grown nicely.
Industry RankSector Rank
OM 31.11%
PM (TTM) N/A
GM 55.79%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BNOR is still creating some value.
BNOR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BNOR has been increased compared to 5 years ago.
BNOR has a worse debt/assets ratio than last year.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BNOR has a debt to FCF ratio of 18.99. This is a negative value and a sign of low solvency as BNOR would need 18.99 years to pay back of all of its debts.
With a Debt to FCF ratio value of 18.99, BNOR is not doing good in the industry: 67.24% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.64 is on the high side and indicates that BNOR has dependencies on debt financing.
BNOR has a Debt to Equity ratio of 1.64. This is amonst the worse of the industry: BNOR underperforms 84.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 18.99
Altman-Z N/A
ROIC/WACC0.64
WACC8.88%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

BNOR has a Current Ratio of 1.04. This is a normal value and indicates that BNOR is financially healthy and should not expect problems in meeting its short term obligations.
BNOR's Current ratio of 1.04 is on the low side compared to the rest of the industry. BNOR is outperformed by 81.03% of its industry peers.
BNOR has a Quick Ratio of 1.04. This is a bad value and indicates that BNOR is not financially healthy enough and could expect problems in meeting its short term obligations.
BNOR's Quick ratio of 0.93 is on the low side compared to the rest of the industry. BNOR is outperformed by 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.93
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for BNOR have decreased strongly by -215.83% in the last year.
BNOR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.64%.
Measured over the past years, BNOR shows a quite strong growth in Revenue. The Revenue has been growing by 16.10% on average per year.
EPS 1Y (TTM)-215.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-462.5%
Revenue 1Y (TTM)-11.64%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%5.07%

3.2 Future

Based on estimates for the next years, BNOR will show a very strong growth in Earnings Per Share. The EPS will grow by 68.13% on average per year.
The Revenue is expected to grow by 20.41% on average over the next years. This is a very strong growth
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5YN/A
Revenue Next Year78.78%
Revenue Next 2Y36.07%
Revenue Next 3Y20.41%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -100 -200 -300

4

4. Valuation

4.1 Price/Earnings Ratio

BNOR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
BNOR is valuated cheaply with a Price/Forward Earnings ratio of 6.71.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BNOR indicates a somewhat cheap valuation: BNOR is cheaper than 79.31% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BNOR to the average of the S&P500 Index (20.42), we can say BNOR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.71
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BNOR is valued a bit more expensive than the industry average as 68.97% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BNOR indicates a slightly more expensive valuation: BNOR is more expensive than 65.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.73
EV/EBITDA 7.37
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

BNOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BNOR's earnings are expected to grow with 68.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.96%
EPS Next 3Y68.13%

0

5. Dividend

5.1 Amount

No dividends for BNOR!.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (5/7/2025, 11:22:04 AM)

583.5

+3.5 (+0.6%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners35.59%
Inst Owner ChangeN/A
Ins Owners1.02%
Ins Owner ChangeN/A
Market Cap15.46B
Analysts82.86
Price Target775.2 (32.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-232%
Min EPS beat(2)-415.9%
Max EPS beat(2)-48.1%
EPS beat(4)0
Avg EPS beat(4)-176.45%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)2
Avg EPS beat(8)-91.35%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.47%
Min Revenue beat(2)-11.98%
Max Revenue beat(2)-8.97%
Revenue beat(4)1
Avg Revenue beat(4)-4.6%
Min Revenue beat(4)-11.98%
Max Revenue beat(4)4.82%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.52%
PT rev (3m)7.65%
EPS NQ rev (1m)-16.33%
EPS NQ rev (3m)-32.18%
EPS NY rev (1m)-10.27%
EPS NY rev (3m)-17.9%
Revenue NQ rev (1m)-8.59%
Revenue NQ rev (3m)-33.07%
Revenue NY rev (1m)-5.52%
Revenue NY rev (3m)-10.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.71
P/S 2.13
P/FCF 20.73
P/OCF 4.85
P/B 2.15
P/tB 2.73
EV/EBITDA 7.37
EPS(TTM)-28.72
EYN/A
EPS(NY)86.99
Fwd EY14.91%
FCF(TTM)28.15
FCFY4.82%
OCF(TTM)120.29
OCFY20.61%
SpS273.87
BVpS271.22
TBVpS213.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -10.18%
ROCE 7.36%
ROIC 5.67%
ROICexc 6.19%
ROICexgc 6.54%
OM 31.11%
PM (TTM) N/A
GM 55.79%
FCFM 10.28%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexcg growth 3Y15.21%
ROICexcg growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 18.99
Debt/EBITDA 3.22
Cap/Depr 174.52%
Cap/Sales 33.64%
Interest Coverage 1.87
Cash Conversion 87.17%
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.93
Altman-Z N/A
F-Score3
WACC8.88%
ROIC/WACC0.64
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-462.5%
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.64%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%5.07%
Revenue Next Year78.78%
Revenue Next 2Y36.07%
Revenue Next 3Y20.41%
Revenue Next 5YN/A
EBIT growth 1Y-31.46%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year296.26%
EBIT Next 3Y57.45%
EBIT Next 5YN/A
FCF growth 1Y218.17%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y23.45%
OCF growth 3Y84.65%
OCF growth 5Y4.46%